Matches in Wikidata for { <http://www.wikidata.org/entity/Q46445206> ?p ?o ?g. }
- Q46445206 description "2005 nî lūn-bûn" @default.
- Q46445206 description "2005年の論文" @default.
- Q46445206 description "2005年学术文章" @default.
- Q46445206 description "2005年学术文章" @default.
- Q46445206 description "2005年学术文章" @default.
- Q46445206 description "2005年学术文章" @default.
- Q46445206 description "2005年学术文章" @default.
- Q46445206 description "2005年學術文章" @default.
- Q46445206 description "2005年學術文章" @default.
- Q46445206 description "2005年學術文章" @default.
- Q46445206 description "2005年學術文章" @default.
- Q46445206 description "2005年學術文章" @default.
- Q46445206 description "2005年學術文章" @default.
- Q46445206 description "2005년 논문" @default.
- Q46445206 description "article científic" @default.
- Q46445206 description "article scientific" @default.
- Q46445206 description "article scientifique (publié 2005)" @default.
- Q46445206 description "articol științific" @default.
- Q46445206 description "articolo scientifico" @default.
- Q46445206 description "artigo científico (publicado na 2005)" @default.
- Q46445206 description "artigo científico (publicado na 2005)" @default.
- Q46445206 description "artigo científico" @default.
- Q46445206 description "artikull shkencor" @default.
- Q46445206 description "artikulong pang-agham" @default.
- Q46445206 description "artykuł naukowy" @default.
- Q46445206 description "artículo científico publicado en 2005" @default.
- Q46445206 description "artículu científicu" @default.
- Q46445206 description "bilimsel makale" @default.
- Q46445206 description "bài báo khoa học" @default.
- Q46445206 description "mokslinis straipsnis" @default.
- Q46445206 description "naučni članak" @default.
- Q46445206 description "scienca artikolo" @default.
- Q46445206 description "scientific article" @default.
- Q46445206 description "teaduslik artikkel" @default.
- Q46445206 description "tieteellinen artikkeli" @default.
- Q46445206 description "tudományos cikk" @default.
- Q46445206 description "vedecký článok" @default.
- Q46445206 description "vetenskaplig artikel" @default.
- Q46445206 description "videnskabelig artikel (udgivet 2005)" @default.
- Q46445206 description "vitenskapelig artikkel" @default.
- Q46445206 description "vitskapeleg artikkel" @default.
- Q46445206 description "vědecký článek" @default.
- Q46445206 description "wetenschappelijk artikel" @default.
- Q46445206 description "wissenschaftlicher Artikel" @default.
- Q46445206 description "επιστημονικό άρθρο" @default.
- Q46445206 description "мақолаи илмӣ" @default.
- Q46445206 description "мақолаи илмӣ" @default.
- Q46445206 description "наукова стаття, опублікована в травні 2005" @default.
- Q46445206 description "научна статия" @default.
- Q46445206 description "научная статья" @default.
- Q46445206 description "научни чланак" @default.
- Q46445206 description "научни чланак" @default.
- Q46445206 description "գիտական հոդված" @default.
- Q46445206 description "מאמר מדעי" @default.
- Q46445206 description "سائنسی مضمون" @default.
- Q46445206 description "مقالة علمية" @default.
- Q46445206 description "مقالهٔ علمی" @default.
- Q46445206 description "২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q46445206 description "บทความทางวิทยาศาสตร์" @default.
- Q46445206 description "სამეცნიერო სტატია" @default.
- Q46445206 name "A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder" @default.
- Q46445206 name "A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder" @default.
- Q46445206 type Item @default.
- Q46445206 label "A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder" @default.
- Q46445206 label "A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder" @default.
- Q46445206 prefLabel "A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder" @default.
- Q46445206 prefLabel "A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder" @default.
- Q46445206 P1433 Q46445206-663D6C7C-7808-49AC-9F74-6FCCC3676EA2 @default.
- Q46445206 P1476 Q46445206-A6F98AC0-97E8-43D2-A365-9EB5899B63C4 @default.
- Q46445206 P2093 Q46445206-07745330-C292-4181-BB5D-6D2E60E35C5A @default.
- Q46445206 P2093 Q46445206-3AA957F1-F889-46B3-85CA-F51CA58802ED @default.
- Q46445206 P2093 Q46445206-BBF63931-B73E-45E8-AF0E-D704EB755252 @default.
- Q46445206 P2093 Q46445206-E4D896E5-7941-4D1D-B368-368BF2D93327 @default.
- Q46445206 P2093 Q46445206-FF8A7270-D795-4676-BE6F-5724011942BE @default.
- Q46445206 P2860 Q46445206-12C7291E-FAF5-4FC8-854B-B0CFDBCF745D @default.
- Q46445206 P2860 Q46445206-223ECD5D-657E-4D82-92E9-FBC2CEC1EEEF @default.
- Q46445206 P2860 Q46445206-2AE468CB-EAD3-4F65-9682-5877A8457DA5 @default.
- Q46445206 P2860 Q46445206-3B4CADB5-D93E-4133-A4A6-E98F1CEB1995 @default.
- Q46445206 P2860 Q46445206-4ED31298-69EB-4C6D-BA80-F46827E2041F @default.
- Q46445206 P2860 Q46445206-55726A02-9D60-4985-A89F-E714E5AE68BE @default.
- Q46445206 P2860 Q46445206-5EFA97FD-2AA1-400B-8B21-B354944913C2 @default.
- Q46445206 P2860 Q46445206-61D5AA9D-7A68-41DA-B21B-7293AE0BF7F6 @default.
- Q46445206 P2860 Q46445206-7D3671BB-EFCB-4CE1-B5E9-BB34D9E62FED @default.
- Q46445206 P2860 Q46445206-A913B5DF-0053-4F00-B486-0F38C1F312D2 @default.
- Q46445206 P2860 Q46445206-ADE0CC8A-83A5-4312-8126-E7FC94C71DF5 @default.
- Q46445206 P2860 Q46445206-E09EB7FD-2DEC-4BF0-BB50-C63180F9FE95 @default.
- Q46445206 P304 Q46445206-F48D928B-6C18-40CB-A8A5-D44BB7BC0AEF @default.
- Q46445206 P31 Q46445206-5BE808D3-6E7E-4622-AD7A-3294BE77CE89 @default.
- Q46445206 P31 Q46445206-962c4aa0-bfff-4db8-94be-03c03bce157d @default.
- Q46445206 P356 Q46445206-9B33FECF-88CF-4165-B9EC-5E4AA04DB3AC @default.
- Q46445206 P433 Q46445206-27D0F47C-B275-4A69-8923-8ED3DA81C4B1 @default.
- Q46445206 P478 Q46445206-AC089784-75D9-401F-9A9E-758F2E3EDD65 @default.
- Q46445206 P50 Q46445206-8A86ADF4-4CA4-444A-B025-41858025C71E @default.
- Q46445206 P50 Q46445206-E09E6DA5-CE26-4676-919B-CDE6A343D18D @default.
- Q46445206 P577 Q46445206-DC7E864D-3A03-46DA-B045-34810160D6FE @default.
- Q46445206 P698 Q46445206-C0F456E8-B2DF-4F3E-BEBF-4BAF4C70114B @default.
- Q46445206 P356 J.1464-410X.2005.05454.X @default.
- Q46445206 P698 15839920 @default.
- Q46445206 P1433 Q4835773 @default.
- Q46445206 P1476 "A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder" @default.